Real World Evidence Solutions Market by Component (Dataset (Claims, Clinical, Pharmacy, Patient), Services), Therapeutic Area (Oncology, Cardiovascular, Immunology), End User (Pharmaceuticals, Medical Devices, Payers, Providers) - Global Forecast to 2023

Publisher Name :
Date: 10-Jul-2018
No. of pages: 157
Inquire Before Buying

“The global real world evidence market projected to grow at a CAGR of 14.3%.”

The global real-world evidence market is projected to reach USD 1,348.1 million by 2023 from USD 689.9 million in 2018, at a CAGR of 14.3% during the forecast period. The growth of this market is majorly driven by the rising geriatric population (and the subsequent increase in the prevalence of chronic diseases), shift from volume- to value-based care, and delays in drug development (and the subsequent increase in development costs). However, the reluctance to rely on real-world studies and the lack of universally accepted methodological standards for data collection are restraining the growth of this market.

“The services segment is expected to register the highest CAGR during the forecast period.”

On the basis of component, the real world evidence market is segmented into data sets and services. The services segment is expected to register the highest CAGR during the forecast period. The high growth rate of this segment is mainly due to the rising need to convert data into actionable evidence, growing need to reduce drug development delays, and availability of large amounts of healthcare data are the major factors driving market growth in this segment.

“Pharmaceutical &medical device companies segment expected to grow at the highest CAGR during2018 to 2023.”

Based on end user, the real-world evidence (RWE) market is broadly segmented into pharmaceutical & medical device companies, healthcare providers, healthcare payers, and other end users (academic institutions, patient advocacy groups, and health technology assessment agencies).The pharmaceutical & biopharmaceutical companies segment is the fastest-growing segment in the real world evidence market during the forecast period. The rising demand to assess comparative effectiveness of drugs in actual, real-world use and the value or economic impact from the use of new or existing drugs are the major factors driving the growth of the real world evidence market for pharmaceutical &medical device companies.

“APAC is projected to witness the highest growth during the forecast period.”

North America held the largest share of the global real world evidence market in 2017.On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, due to the increasing government initiatives for the adoption of RWE studies, rising burden of chronic diseases, increasing demand for better healthcare services, and the rising geriatric population in the Asia Pacific region.

Break of primary participants was as mentioned below:


  • By Company Type – Tier 1–25%, Tier 2–50% and Tier 3–25%

  • By Designation – C-level–25%, Director Level–37%, Others–38%

  • By Region – North America–25%, Europe–25%, Asia Pacific–37%, Rest of World–13%


The prominent players in the global real world evidence market are IQVIA (US), International Business Machines Corporation (US), ICON (Ireland), PAREXEL (US), Pharmaceutical Product Development (US), Optum (US), Cognizant (US), Oracle (US), SAS (US), Syneos Health (US), Anthem (US), Clinigen Group (UK), Palantir Technologies (UK), and Flatiron Health (US).

Research Coverage:

The report analyzes the various real world evidence and their adoption pattern. It aims at estimating the market size and future growth potential of the global real world evidence market for different segments such asby component, therapeutic area, end user,and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them,garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:


  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global real world evidence market. The report analyzes the global real world evidence market by component, therapeutic area, end user, and region

  • Service Development/Innovation: Detailed insights on upcoming trends and service launches in the global real world evidence market

  • Market Development: Comprehensive information on the lucrative emerging regions by component, therapeutic area, end user, and region

  • Market Diversification: Exhaustive information about new services, growing geographies, and recent developments in the global real world evidence market

  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and services of leading players in the global real world evidence market

Real World Evidence Solutions Market by Component (Dataset (Claims, Clinical, Pharmacy, Patient), Services), Therapeutic Area (Oncology, Cardiovascular, Immunology), End User (Pharmaceuticals, Medical Devices, Payers, Providers) - Global Forecast to 2023

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.4 Years Considered for the Study
1.5 Limitations
1.6 Currency
1.7 Stakeholders

2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Source
2.1.2.2 Breakdown of Primary Interviews
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Real-World Evidence: Market Overview
4.2 Europe Real-World Evidence Market, By Therapeutic Area and Country
4.3 Market: Geographic Snapshot
4.4 Real-World Evidence: Geographic Mix

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Geriatric Population and the Subsequent Increase in the Prevalence of Chronic Diseases
5.2.1.2 Shift From Volume- to Value-Based Care
5.2.1.3 Delays in Drug Development and the Subsequent Increase in Development Costs
5.2.2 Restraints
5.2.2.1 Reluctance to Rely on Real-World Studies
5.2.3 Opportunities
5.2.3.1 Growth Opportunities in Emerging Markets
5.2.3.2 Rising Focus on End-To-End Rwe Services
5.2.4 Challenges
5.2.4.1 Lack of Universally Accepted Methodological Standards and Data Processing Infrastructure

6 Industry Trends
6.1 Industry Trends
6.1.1 Emerging Role of Wearable Devices
6.1.2 Social Media Sourced Real-World Evidence
6.1.3 Incorporation of Artificial Intelligence in Real-World Data Management
6.2 Real-World Data Sources

7 Real-World Evidence Market, By Component
7.1 Introduction
7.2 Data Sets
7.2.1 Clinical Settings Data
7.2.2 Claims Data
7.2.3 Pharmacy Data
7.2.4 Patient-Powered Data
7.3 Services

8 Real-World Evidence Market, By Therapeutic Area
8.1 Introduction
8.2 Oncology
8.3 Cardiovascular Disease
8.4 Neurology
8.5 Immunology
8.6 Other Therapeutic Areas

9 Real-World Evidence Market, By End User
9.1 Introduction
9.2 Pharmaceutical & Medical Device Companies
9.3 Healthcare Payers
9.4 Healthcare Providers
9.5 Other End Users

10 Real-World Evidence Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 Rest of APAC
10.5 Rest of the World

11 Competitive Landscape
11.1 Overview
11.2 Competitive Scenario
11.2.1 Mergers & Acquisitions
11.2.2 Partnerships, Agreements, Alliances, and Collaborations
11.2.3 Services Launches

12 Company Profiles
(Business Overview, Services Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 Iqvia
12.2 IBM
12.3 Pharmaceutical Product Development
12.4 Parexel
12.5 Optum (A Subsidiary of United Health Group, Inc.)
12.6 Perkinelmer
12.7 Icon PLC
12.8 Oracle
12.9 Cognizant
12.10 Syneos Health
12.11 Anthem
12.12 Clinigen
12.13 SAS Institute

*Details on Business Overview, Services Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Available Customizations
13.5 Related Reports
13.6 Author Details

List of Tables

Table 1 Standard Currency Conversion Rates
Table 2 Drivers: Impact Analysis
Table 3 Restraints: Impact Analysis
Table 4 Opportunities: Impact Analysis
Table 5 Challenges: Impact Analysis
Table 6 Indicative List of National Databases in Developed Countries
Table 7 Market, By Component, 2016–2023 (USD Million)
Table 8 Real-World Evidence Data Sets Market, By Type, 2016–2023 (USD Million)
Table 9 Real-World Evidence Data Sets Market, By Country, 2016–2023 (USD Million)
Table 10 Real-World Evidence Clinical Settings Data Market, By Country, 2016–2023 (USD Million)
Table 11 Real-World Evidence Claims Data Market, By Country, 2016–2023 (USD Million)
Table 12 Real-World Evidence Pharmacy Data Market, By Country, 2016–2023 (USD Million)
Table 13 Real-World Evidence Patient-Powered Data Market, By Country, 2016–2023 (USD Million)
Table 14 Real-World Evidence Services Market, By Country, 2016–2023 (USD Million)
Table 15 Real-World Evidence Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 16 Market for Oncology, By Country, 2016–2023 (USD Million)
Table 17 Market for Cardiovascular Disease, By Country, 2016–2023 (USD Million)
Table 18 Market for Neurology, By Country, 2016–2023 (USD Million)
Table 19 Market for Immunology, By Country, 2016–2023 (USD Million)
Table 20 Real-World Evidence Market for Other Therapeutic Areas, By Country, 2016–2023 (USD Million)
Table 21 Market, By End User, 2016–2023 (USD Million)
Table 22 Market for Pharmaceutical & Medical Device Companies, By Country, 2016–2023 (USD Million)
Table 23 Real-World Evidence Market for Healthcare Payers, By Country, 2016–2023 (USD Million)
Table 24 Market for Healthcare Providers, By Country, 2016–2023 (USD Million)
Table 25 Market for Other End Users, By Country, 2016–2023 (USD Million)
Table 26 Market, By Region, 2016–2023 (USD Million)
Table 27 North America: Market, By Country, 2016–2023 (USD Million)
Table 28 North America: Market, By Component, 2016–2023 (USD Million)
Table 29 North America: Real-World Evidence Data Sets Market, By Type, 2016–2023 (USD Million)
Table 30 North America: Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 31 North America: Real-World Evidence Market, By End User, 2016–2023 (USD Million)
Table 32 US: Market, By Component, 2016–2023 (USD Million)
Table 33 US: Real-World Evidence Data Sets Market, By Type, 2016–2023 (USD Million)
Table 34 US: Real-World Evidence Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 35 US: Market, By End User, 2016–2023 (USD Million)
Table 36 Canada: Market, By Component, 2016–2023 (USD Million)
Table 37 Canada: Real-World Evidence Data Sets Market, By Type, 2016–2023 (USD Million)
Table 38 Canada: Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 39 Canada: Market, By End User, 2016–2023 (USD Million)
Table 40 Europe: Market, By Country, 2016–2023 (USD Million)
Table 41 Europe: Market, By Component, 2016–2023 (USD Million)
Table 42 Europe: Real-World Evidence Data Sets Market, By Type, 2016–2023 (USD Million)
Table 43 Europe: Real-World Evidence Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 44 Europe: Market, By End User, 2016–2023 (USD Million)
Table 45 Germany: Market, By Component, 2016–2023 (USD Million)
Table 46 Germany: Real-World Evidence Data Sets Market, By Type, 2016–2023 (USD Million)
Table 47 Germany: Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 48 Germany: Market, By End User, 2016–2023 (USD Million)
Table 49 UK: Market, By Component, 2016–2023 (USD Million)
Table 50 UK: Real-World Evidence Data Sets Market, By Type, 2016–2023 (USD Million)
Table 51 UK: Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 52 UK: Real-World Evidence Market, By End User, 2016–2023 (USD Million)
Table 53 France: Market, By Component, 2016–2023 (USD Million)
Table 54 France: Real-World Evidence Data Sets Market, By Type, 2016–2023 (USD Million)
Table 55 France: Real-World Evidence Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 56 France: Market, By End User, 2016–2023 (USD Million)
Table 57 Italy: Market, By Component, 2016–2023 (USD Million)
Table 58 Italy: Real-World Evidence Data Sets Market, By Type, 2016–2023 (USD Million)
Table 59 Italy: Real-World Evidence Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 60 Italy: Market, By End User, 2016–2023 (USD Million)
Table 61 Spain: Market, By Component, 2016–2023 (USD Million)
Table 62 Spain: Real-World Evidence Data Sets Market, By Type, 2016–2023 (USD Million)
Table 63 Spain: Real-World Evidence Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 64 Spain: Market, By End User, 2016–2023 (USD Million)
Table 65 RoE: Market, By Component, 2016–2023 (USD Million)
Table 66 RoE: Real-World Evidence Data Sets Market, By Type, 2016–2023 (USD Million)
Table 67 RoE: Real-World Evidence Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 68 RoE: Market, By End User, 2016–2023 (USD Million)
Table 69 Asia Pacific: Market, By Component, 2016–2023 (USD Million)
Table 70 Asia Pacific: Real-World Evidence Data Sets Market, By Type, 2016–2023 (USD Million)
Table 71 Asia Pacific: Real-World Evidence Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 72 Asia Pacific: Market, By End User, 2016–2023 (USD Million)
Table 73 Japan: Market, By Component, 2016–2023 (USD Million)
Table 74 Japan: Real-World Evidence Data Sets Market, By Type, 2016–2023 (USD Million)
Table 75 Japan: Real-World Evidence Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 76 Japan: Market, By End User, 2016–2023 (USD Million)
Table 77 China: Market, By Component, 2016–2023 (USD Million)
Table 78 China: Real-World Evidence Data Sets Market, By Type, 2016–2023 (USD Million)
Table 79 China: Real-World Evidence Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 80 China: Market, By End User, 2016–2023 (USD Million)
Table 81 RoAPAC: Market, By Component, 2016–2023 (USD Million)
Table 82 RoAPAC: Real-World Evidence Data Sets Market, By Type, 2016–2023 (USD Million)
Table 83 RoAPAC: Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 84 RoAPAC: Market, By End User, 2016–2023 (USD Million)
Table 85 RoW: Market, By Component, 2016–2023 (USD Million)
Table 86 RoW: Real-World Evidence Data Sets Market, By Type, 2016–2023 (USD Million)
Table 87 RoW: Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 88 RoW: Real-World Evidence Market, By End User, 2016–2023 (USD Million)
Table 89 Growth Strategy Matrix (2014–2018)
Table 90 Acquisitions, 2014–2018
Table 91 Partnerships, Agreements, Alliances, and Collaborations, 2014–2017
Table 92 Service Launches, 2014–2017

List of Figures

Figure 1 Real-World Evidence Market Segmentation
Figure 2 Research Design
Figure 3 Data Triangulation Methodology
Figure 4 Market, By Component, 2018 vs 2023 (USD Million)
Figure 5 Market, By Therapeutic Area, 2018 vs 2023 (USD Million)
Figure 6 Market, By End User, 2018 vs 2023 (USD Million)
Figure 7 Geographic Snapshot of the Real-World Evidence Market
Figure 8 Market is Projected to Witness A Double-Digit Growth in the Forecast Period
Figure 9 Oncology Segment Commanded the Largest Share of the Market in 2017
Figure 10 The US Accounted for the Largest Share of the Market in 2017
Figure 11 APAC to Register the Highest CAGR During the Forecast Period
Figure 12 Real-World Evidence Market: Drivers, Restraints, Opportunities, and Challenges
Figure 13 Growth in Geriatric Population, By Region (2015–2050)
Figure 14 Utilization of Wearables in Clinical Trials, By Therapeutic Area (2016)
Figure 15 Data Sets to Form the Largest Component Segment in the Market During the Forecast Period
Figure 16 EHR Adoption By Office-Based Physicians, US (2006–2015)
Figure 17 E-Prescribing Utilization Among Pharmacies and Prescribers in the US (2013–2017)
Figure 18 Increase in Clinical Trials During 2010–2017, By Therapeutic Area
Figure 19 Oncology Segment Will Continue to Dominate the Market By 2023
Figure 20 Pharmaceutical & Medical Device Companies to Continue to Dominate the Market in 2023
Figure 21 FDA Phase Transition Success Rates, 2006–2015
Figure 22 Market: Geographical Growth Opportunities
Figure 23 North America: Market Snapshot
Figure 24 Clinical Trials in Canada (2013–2017)
Figure 25 Europe: Real-World Evidence Market Snapshot
Figure 26 Adult Wearable Device User Base and Internet Penetration in China (2015–2019)
Figure 27 Number of Observational Studies in China, 2013–2017
Figure 28 Key Developments in the Market Between 2014 and 2018
Figure 29 Iqvia: Company Snapshot (2017)
Figure 30 IBM Corporation: Company Snapshot (2017)
Figure 31 Parexel: Company Snapshot (2017)
Figure 32 Optum: Company Snapshot (2017)
Figure 33 Perkinelmer: Company Snapshot (2017)
Figure 34 Icon PLC: Company Snapshot (2017)
Figure 35 Oracle: Company Snapshot (2017)
Figure 36 Cognizant: Company Snapshot (2017)
Figure 37 Syneos Health: Company Snapshot (2017)
Figure 38 Anthem, Inc.: Company Snapshot (2017)
Figure 39 Clinigen: Company Snapshot (2017)
Figure 40 SAS Institute: Company Snapshot (2017)

  • Global Hot and Cold Therapy Packs Sales Market Report 2018
    Published: 19-Jul-2018        Price: US 4000 Onwards        Pages: 106
    This report studies the global Hot and Cold Therapy Packs market status and forecast, categorizes the global Hot and Cold Therapy Packs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). The global Hot and Cold Therapy Packs market is valued at million US$ in 2017 and will reach million US$ b......
  • Blockchain Technology in Healthcare Market by Application (Supply Chain Management, Clinical Data Exchange & Interoperability, Claims Adjudication and Billing), End User (Pharmaceutical Companies, Healthcare Payers, Providers) - Global Forecast to 2023
    Published: 18-Jul-2018        Price: US 5650 Onwards        Pages: 128
    “Blockchain technology in the healthcare market is projected to grow at a CAGR of 72.8%.” The healthcare blockchain market is expected to reach USD 829.0 million by 2023 from USD 53.9 million in 2018, at a CAGR of 72.8%. The increasing incidence of healthcare data breaches, rising threat of counterfeit drugs, increasing adoption of blockchain as a service (BaaS), and the transparency & immutability of the distributed ledger technology are major factors......
  • Global Nurse Call Systems Market Size, Status and Forecast 2025
    Published: 12-Jul-2018        Price: US 3300 Onwards        Pages: 99
    This report studies the global Nurse Call Systems market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Nurse Call Systems market by companies, region, type and end-use industry. In 2017, the global Nurse Call Systems market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. This report focuses on the global top players, co......
  • 2018-2023 Global Medical Waste Management Market Report (Status and Outlook)
    Published: 12-Jul-2018        Price: US 4660 Onwards        Pages: 139
    In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Medical Waste Management market for 2018-2023. Medical waste management offers the full complement of medical waste disposal including solid waste, pharmaceutical waste, and document destruction. Medical waste is a subset of wastes generated at health care facilities, such as hospitals, physicians' offices, dental practices, blood banks, and veterinary hos......
  • Global and United States Marijuana Market Research by Company, Type & Application 2013-2025
    Published: 12-Jul-2018        Price: US 2000 Onwards        Pages: 114
    Summary Market Segment as follows: By Type Industrial Grade Pharmaceutical Grade By Application Chronic Pain Arthritis Migraine Cancer Others By Company Cara Therapeutics Cannabis Sativa CannaGrow Holdings United Cannabis Growblox Sciences GreenGro Technologies GW Pharmaceuticals Lexaria Corp MMJ America ......
  • Global and United States Tylosin Base (CAS 1401-69-0) Market Research by Company, Type & Application 2013-2025
    Published: 11-Jul-2018        Price: US 2000 Onwards        Pages: 94
    Summary Market Segment as follows: By Type Crystallization Liquid By Application Feed Additives Poultry Medicine By Company Eli Lilly (USA) Huvepharma (Bulgaria) Shandong Lukang (China) Hengtong Guanghua (China) Ningxia Tairui (China) The main contents of the report including: Section 1: Product definition, type and application, global and United States market overv......
  • Global and United States Pyelonephritis Drug Market Research by Company, Type & Application 2013-2025
    Published: 11-Jul-2018        Price: US 2000 Onwards        Pages: 115
    Summary Market Segment as follows: By Type Finafloxacin Fosfomycin Tromethamine Nacubactam Plazomicin Sulfate Others By Application Hospital Clinic Others By Company Achaogen Inc AstraZeneca Plc Meiji Seika Pharma Co Ltd Merck & Co Inc MerLion Pharmaceuticals Pte Ltd The Medicines Company Zavante Therapeutics Inc The m......
  • Global and United States CBD Hemp Oil Market Research by Company, Type & Application 2013-2025
    Published: 11-Jul-2018        Price: US 2000 Onwards        Pages: 123
    Summary Market Segment as follows: By Type Food Grade Pharmaceutical Grade By Application Anxiety Fibromyalgia (FM) Diabetes Others By Company ENDOCA CBD American Shaman Gaia Botanicals Isodiol Medical Marijuana Aurora Cannabis (AC) Cannoid Canopy Growth Corporation CV Sciences IRIE CBD Elixinol ......
  • Global and United States Pharma Track and Trace Solutions Market Research by Company, Type & Application 2013-2025
    Published: 10-Jul-2018        Price: US 2000 Onwards        Pages: 120
    Summary Market Segment as follows: By Type Barcodes RFID By Application Bio Pharma Chemical Pharma Specially Pharma By Company Optel Vision Siemens IBM Axway Mettler-Toledo Systech SAP Seidenader Maschinenbau Antares Vision Sea Vision TraceLink Adents International Xyntek Holoflex......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs